{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:56:10Z","timestamp":1792403770474,"version":"4.4.0"},"reference-count":90,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.1001\/jamapsychiatry.2022.0645","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T11:01:34Z","timestamp":1650452494000},"page":"571","source":"Crossref","is-referenced-by-count":95,"title":["Cerebrospinal Fluid Biomarkers in Patients With Unipolar Depression Compared With Healthy Control Individuals"],"prefix":"10.1001","volume":"79","author":[{"given":"Ina Viktoria","family":"Mousten","sequence":"first","affiliation":[{"name":"Biological and Precision Psychiatry, Copenhagen Research Centre for Mental Health, Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina Vindegaard","family":"S\u00f8rensen","sequence":"additional","affiliation":[{"name":"Biological and Precision Psychiatry, Copenhagen Research Centre for Mental Health, Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark"},{"name":"Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune Haubo B.","family":"Christensen","sequence":"additional","affiliation":[{"name":"Biological and Precision Psychiatry, Copenhagen Research Centre for Mental Health, Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Eriksen","family":"Benros","sequence":"additional","affiliation":[{"name":"Biological and Precision Psychiatry, Copenhagen Research Centre for Mental Health, Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark"},{"name":"Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10159","key":"yoi220017r1","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"yoi220017r2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.15171\/apb.2019.044","article-title":"5-HIAA as a potential biological marker for neurological and psychiatric disorders.","volume":"9","author":"Jayamohananan","year":"2019","journal-title":"Adv Pharm Bull"},{"issue":"1","key":"yoi220017r3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"issue":"7","key":"yoi220017r4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2174\/1570159X14666151208113006","article-title":"Stress, the autonomic nervous system, and the immune-kynurenine pathway in the etiology of depression.","volume":"14","author":"Won","year":"2016","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"yoi220017r5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target.","volume":"16","author":"Miller","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"yoi220017r6","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1017\/S1461145708009309","article-title":"A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression.","volume":"11","author":"Brunoni","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"yoi220017r7","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1172\/JCI68241","article-title":"Bathing the brain.","volume":"123","author":"Strittmatter","year":"2013","journal-title":"J Clin Invest"},{"issue":"12","key":"yoi220017r8","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/archpsyc.1979.01780120111013","article-title":"Research diagnostic criteria.","volume":"36","author":"Spitzer","year":"1979","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"yoi220017r9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/archpsyc.1972.01750190059011","article-title":"Diagnostic criteria for use in psychiatric research.","volume":"26","author":"Feighner","year":"1972","journal-title":"Arch Gen Psychiatry"},{"issue":"561","key":"yoi220017r10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1192\/bjp.121.2.162","article-title":"Studies in the classification of affective disorders. the relationship between anxiety states and depressive illnesses. II.","volume":"121","author":"Gurney","year":"1972","journal-title":"Br J Psychiatry"},{"issue":"3","key":"yoi220017r13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"1-3","key":"yoi220017r14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.schres.2012.01.014","article-title":"Treatment response trajectories and antipsychotic medications: examination of up to 18 months of treatment in the CATIE Chronic Schizophrenia trial.","volume":"137","author":"Levine","year":"2012","journal-title":"Schizophr Res"},{"issue":"2","key":"yoi220017r15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3102\/10769986006002107","article-title":"Distribution theory for Glass\u2019s estimator of effect size and related estimators.","volume":"6","author":"Hedges","year":"1981","journal-title":"J Educ Behav Stat"},{"issue":"2","key":"yoi220017r16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1037\/0033-2909.92.2.490","article-title":"Estimation of effect size from a series of independent experiments.","volume":"92","author":"Hedges","year":"1982","journal-title":"Psychol Bull"},{"issue":"7109","key":"yoi220017r18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"yoi220017r19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial.","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"issue":"1","key":"yoi220017r20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0165-1781(81)90004-4","article-title":"Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy control individuals.","volume":"4","author":"Oreland","year":"1981","journal-title":"Psychiatry Res"},{"issue":"8","key":"yoi220017r21","first-page":"877","article-title":"Cerebrospinal fluid ?-aminobutyric acid and homovanillic acid in depressive disorders.","volume":"17","author":"Kasa","year":"1982","journal-title":"Biol Psychiatry"},{"issue":"9","key":"yoi220017r22","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/archpsyc.1983.01790080081011","article-title":"CSF and urinary biogenic amines and metabolites in depression and mania. a controlled, univariate analysis.","volume":"40","author":"Koslow","year":"1983","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"yoi220017r23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/acp.1984.69.issue-3","article-title":"CSF monoamine metabolites in melancholia.","volume":"69","author":"\u00c5sberg","year":"1984","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"yoi220017r24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0165-0327(88)90051-1","article-title":"Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients.","volume":"14","author":"Widerl\u00f6v","year":"1988","journal-title":"J Affect Disord"},{"issue":"9","key":"yoi220017r25","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1176\/ajp.148.9.1189","article-title":"Lateral ventricle-brain ratio and balance between CSF HVA and 5-HIAA in schizophrenia.","volume":"148","author":"Lewine","year":"1991","journal-title":"Am J Psychiatry"},{"issue":"11","key":"yoi220017r26","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/0006-3223(91)90253-I","article-title":"CSF monoamine metabolites and somatostatin in Alzheimer\u2019s disease and major depression.","volume":"29","author":"Molchan","year":"1991","journal-title":"Biol Psychiatry"},{"issue":"8-9","key":"yoi220017r27","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/0006-3223(93)90103-K","article-title":"Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.","volume":"33","author":"De Bellis","year":"1993","journal-title":"Biol Psychiatry"},{"issue":"8","key":"yoi220017r28","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0006-3223(98)00172-3","article-title":"Psychomotor performance and monoamine function in bipolar and unipolar affective disorders.","volume":"45","author":"Swann","year":"1999","journal-title":"Biol Psychiatry"},{"issue":"2","key":"yoi220017r29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0022-3956(03)00101-8","article-title":"Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism.","volume":"38","author":"Heilig","year":"2004","journal-title":"J Psychiatr Res"},{"issue":"2","key":"yoi220017r30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.euroneuro.2004.09.009","article-title":"Higher cerebrospinal fluid homovanillic acid levels in depressed patients with comorbid posttraumatic stress disorder.","volume":"15","author":"Sher","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"yoi220017r31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jad.2005.10.002","article-title":"Lower cerebrospinal fluid homovanillic acid levels in depressed suicide attempters.","volume":"90","author":"Sher","year":"2006","journal-title":"J Affect Disord"},{"issue":"5","key":"yoi220017r32","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.biopsych.2005.11.022","article-title":"Low cerebrospinal fluid transthyretin levels in depression: correlations with suicidal ideation and low serotonin function.","volume":"60","author":"Sullivan","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"5","key":"yoi220017r33","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1017\/S1461145705006231","article-title":"Elevated cerebrospinal fluid 5-hydroxyindoleacetic acid levels in women with comorbid depression and panic disorder.","volume":"9","author":"Sullivan","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"yoi220017r34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s00415-009-5353-6","article-title":"Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson\u2019s disease and major depression.","volume":"257","author":"P\u00e5lhagen","year":"2010","journal-title":"J Neurol"},{"key":"yoi220017r35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/srep00667","article-title":"Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile.","volume":"2","author":"Kaddurah-Daouk","year":"2012","journal-title":"Sci Rep"},{"issue":"8","key":"yoi220017r36","doi-asserted-by":"publisher","first-page":"e947","DOI":"10.4088\/JCP.16m11144","article-title":"Relationships of cerebrospinal fluid monoamine metabolite levels with clinical variables in major depressive disorder.","volume":"78","author":"Yoon","year":"2017","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"yoi220017r37","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1176\/ajp.138.8.1098","article-title":"CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa.","volume":"138","author":"Gerner","year":"1981","journal-title":"Am J Psychiatry"},{"issue":"3","key":"yoi220017r38","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1017\/S0033291700022248","article-title":"CSF GABA in depressed patients and normal control individuals.","volume":"21","author":"Roy","year":"1991","journal-title":"Psychol Med"},{"issue":"10","key":"yoi220017r39","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/da.2014.31.issue-10","article-title":"Anxiety in major depression and cerebrospinal fluid free gamma-aminobutyric acid.","volume":"31","author":"Mann","year":"2014","journal-title":"Depress Anxiety"},{"key":"yoi220017r40","doi-asserted-by":"publisher","first-page":"7796","DOI":"10.1038\/srep07796","article-title":"Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder.","volume":"5","author":"Ogawa","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"yoi220017r41","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1176\/ajp.140.1.92","article-title":"CSF cortisol in patients with depression, mania, or anorexia nervosa and in normal subjects.","volume":"140","author":"Gerner","year":"1983","journal-title":"Am J Psychiatry"},{"issue":"3","key":"yoi220017r42","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/archpsyc.1984.01790140047006","article-title":"Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. a multicenter study.","volume":"41","author":"Stokes","year":"1984","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"yoi220017r43","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1176\/ajp.156.5.710","article-title":"Low levels of transthyretin in the CSF of depressed patients.","volume":"156","author":"Sullivan","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"4","key":"yoi220017r44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archpsyc.1983.01790040063009","article-title":"CSF somatostatin in affective illness.","volume":"40","author":"Rubinow","year":"1983","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"yoi220017r45","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/archpsyc.1986.01800120034008","article-title":"Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders.","volume":"43","author":"Bissette","year":"1986","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"yoi220017r46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1520-6394(1998)8:2<71::AID-DA5>3.0.CO;2-N","article-title":"Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy control individuals: response to amitriptyline treatment.","volume":"8","author":"Heuser","year":"1998","journal-title":"Depress Anxiety"},{"issue":"1-3","key":"yoi220017r47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0165-0327(02)00460-3","article-title":"Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression.","volume":"79","author":"Carpenter","year":"2004","journal-title":"J Affect Disord"},{"issue":"3","key":"yoi220017r48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biopsych.2009.01.030","article-title":"Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.","volume":"66","author":"Lindqvist","year":"2009","journal-title":"Biol Psychiatry"},{"issue":"1","key":"yoi220017r49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/da.20876","article-title":"Proinflammatory and \u201cresiliency\u201d proteins in the CSF of patients with major depression.","volume":"29","author":"Martinez","year":"2012","journal-title":"Depress Anxiety"},{"issue":"3","key":"yoi220017r50","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jpsychires.2012.12.001","article-title":"Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder.","volume":"47","author":"Sasayama","year":"2013","journal-title":"J Psychiatr Res"},{"issue":"1","key":"yoi220017r51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2014.05.006","article-title":"Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. results from a population-based sample.","volume":"41","author":"Kern","year":"2014","journal-title":"Brain Behav Immun"},{"key":"yoi220017r52","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jad.2021.03.012","article-title":"Evidence of upregulation of the cholinergic anti-inflammatory pathway in late-life depression.","volume":"286","author":"Pomara","year":"2021","journal-title":"J Affect Disord"},{"issue":"1","key":"yoi220017r53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-3956(99)00026-6","article-title":"Elevated concentration of N-CAM VASE isoforms in schizophrenia.","volume":"34","author":"Vawter","year":"2000","journal-title":"J Psychiatr Res"},{"key":"yoi220017r54","doi-asserted-by":"crossref","first-page":"11412","DOI":"10.1038\/srep11412","article-title":"Increased cerebrospinal fluid fibrinogen in major depressive disorder.","volume":"5","author":"Hattori","year":"2015","journal-title":"Sci Rep"},{"key":"yoi220017r55","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jpsychires.2019.03.024","article-title":"Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia.","volume":"113","author":"Mizui","year":"2019","journal-title":"J Psychiatr Res"},{"issue":"11","key":"yoi220017r56","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/ijnp\/pyaa049","article-title":"Increased matrix metalloproteinases in cerebrospinal fluids of patients with major depressive disorder and schizophrenia.","volume":"23","author":"Omori","year":"2020","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"yoi220017r57","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/1531-8249(199904)45:4<504::AID-ANA12>3.0.CO;2-9","article-title":"Cerebrospinal fluid A42 is increased early in sporadic Alzheimer\u2019s disease and declines with disease progression.","volume":"45","author":"Jensen","year":"1999","journal-title":"Ann Neurol"},{"issue":"4","key":"yoi220017r58","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3233\/JAD-2010-100207","article-title":"Evaluation of CSF biomarkers as predictors of Alzheimer\u2019s disease: a clinical follow-up study of 4.7 years.","volume":"21","author":"Hertze","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"yoi220017r59","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1176\/appi.ajp.2011.11081153","article-title":"Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder.","volume":"169","author":"Pomara","year":"2012","journal-title":"Am J Psychiatry"},{"issue":"6","key":"yoi220017r60","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/geronb\/gbu096","article-title":"Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression.","volume":"69","author":"Diniz","year":"2014","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"issue":"3","key":"yoi220017r61","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","article-title":"The role of dopamine in the pathophysiology of depression.","volume":"64","author":"Dunlop","year":"2007","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"yoi220017r62","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/mp.2010.120","article-title":"The GABAergic deficit hypothesis of major depressive disorder.","volume":"16","author":"Luscher","year":"2011","journal-title":"Mol Psychiatry"},{"issue":"4","key":"yoi220017r63","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2174\/1570159X1304150831150507","article-title":"The effects of psychological stress on depression.","volume":"13","author":"Yang","year":"2015","journal-title":"Curr Neuropharmacol"},{"issue":"6","key":"yoi220017r64","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S1734-1140(13)71525-1","article-title":"Involvement of prolactin and somatostatin in depression and the mechanism of action of antidepressant drugs.","volume":"65","author":"Faron-G\u00f3recka","year":"2013","journal-title":"Pharmacol Rep"},{"key":"yoi220017r65","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fphar.2013.00110","article-title":"Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?","volume":"4","author":"Lin","year":"2013","journal-title":"Front Pharmacol"},{"issue":"suppl 2","key":"yoi220017r66","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar1917","article-title":"Interleukin-6 and chronic inflammation.","volume":"8","author":"Gabay","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"yoi220017r67","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s00415-018-09174-z","article-title":"Adult CSF total protein upper reference limits should be age-partitioned and significantly higher than 0.45 g\/L: a systematic review.","volume":"266","author":"Breiner","year":"2019","journal-title":"J Neurol"},{"issue":"6","key":"yoi220017r68","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41380-018-0220-4","article-title":"Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.","volume":"24","author":"Orlovska-Waast","year":"2019","journal-title":"Mol Psychiatry"},{"issue":"9","key":"yoi220017r69","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development.","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"yoi220017r70","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1007\/s12035-018-1283-6","article-title":"Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation.","volume":"56","author":"Lima Giacobbo","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"1","key":"yoi220017r71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0004867419857811","article-title":"A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: a \u2018C-reactive protein\u2019 for psychiatrists and neurologists?","volume":"54","author":"Eratne","year":"2020","journal-title":"Aust N Z J Psychiatry"},{"issue":"240","key":"yoi220017r73","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jad.2018.07.031","article-title":"Poor evidence for putative abnormalities in cerebrospinal fluid neurotransmitters in patients with depression versus healthy non-psychiatric individuals: a systematic review and meta-analyses of 23 studies.","volume":"240","author":"Pech","year":"2018","journal-title":"J Affect Disord"},{"key":"yoi220017r74","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpsychires.2018.08.028","article-title":"Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: a meta-analysis of historic evidence.","volume":"105","author":"Ogawa","year":"2018","journal-title":"J Psychiatr Res"},{"issue":"1","key":"yoi220017r75","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1503\/jpn.160228","article-title":"Meta-analysis of central and peripheral ?-aminobutyric acid levels in patients with unipolar and bipolar depression.","volume":"43","author":"Romeo","year":"2018","journal-title":"J Psychiatry Neurosci"},{"issue":"6","key":"yoi220017r76","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.3390\/ijms21062075","article-title":"Undiscovered roles for transthyretin: from a transporter protein to a new therapeutic target for Alzheimer\u2019s disease.","volume":"21","author":"Gi\u00e3o","year":"2020","journal-title":"Int J Mol Sci"},{"key":"yoi220017r77","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jad.2014.11.044","article-title":"BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis.","volume":"174","author":"Polyakova","year":"2015","journal-title":"J Affect Disord"},{"issue":"1","key":"yoi220017r78","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/schbul\/sbx035","article-title":"Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression.","volume":"44","author":"Wang","year":"2018","journal-title":"Schizophr Bull"},{"key":"yoi220017r79","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","article-title":"Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue.","volume":"81","author":"Enache","year":"2019","journal-title":"Brain Behav Immun"},{"issue":"5","key":"yoi220017r80","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jpsychires.2009.08.008","article-title":"Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction.","volume":"44","author":"Bechter","year":"2010","journal-title":"J Psychiatr Res"},{"issue":"4","key":"yoi220017r81","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archpsyc.62.4.397","article-title":"Neuroanatomic correlates of psychopathologic components of major depressive disorder.","volume":"62","author":"Milak","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"yoi220017r82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3949\/ccjm.75.1.57","article-title":"The STAR*D study: treating depression in the real world.","volume":"75","author":"Gaynes","year":"2008","journal-title":"Cleve Clin J Med"},{"issue":"2-3","key":"yoi220017r83","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jad.2012.03.033","article-title":"Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.","volume":"141","author":"Abbasi","year":"2012","journal-title":"J Affect Disord"},{"issue":"1","key":"yoi220017r84","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"yoi220017r85","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41398-020-00933-z","article-title":"Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder.","volume":"10","author":"Zhan","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"5","key":"yoi220017r86","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","article-title":"Antidepressant drugs act by directly binding to TRKB neurotrophin receptors.","volume":"184","author":"Casarotto","year":"2021","journal-title":"Cell"},{"key":"yoi220017r87","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbr.2017.04.020","article-title":"The influence of stress on neuroinflammation and alterations in brain structure and function in major depressive disorder.","volume":"329","author":"Kim","year":"2017","journal-title":"Behav Brain Res"},{"issue":"1","key":"yoi220017r88","first-page":"64","article-title":"The utility of CSF for the diagnosis of primary and secondary monoamine neurotransmitter deficiencies.","volume":"28","author":"Burlina","year":"2017","journal-title":"EJIFCC"},{"issue":"12","key":"yoi220017r89","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1176\/ajp.141.12.1533","article-title":"CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal control individuals.","volume":"141","author":"Gerner","year":"1984","journal-title":"Am J Psychiatry"},{"key":"yoi220017r12","volume-title":"GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations","author":"Sch\u00fcnemann"},{"key":"yoi220017r17","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"yoi220017r11","unstructured":"The Cochrane Collaboration. Newcastle-Ottawa Quality Assessment Scale Case Control Studies. Accessed August 19, 2021. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/nosgen.pdf"},{"key":"yoi220017r72","unstructured":"Commonly prescribed antidepressants and how they work. NIH MedlinePlus Magazine. Accessed June 3, 2021. https:\/\/magazine.medlineplus.gov\/article\/commonly-prescribed-antidepressants-and-how-they-work"},{"key":"yoi220017r90","doi-asserted-by":"crossref","unstructured":"Powell? TR, Gaspar? H, Chung? R, . Assessing 42 inflammatory markers in 321 control subjects and 887 major depressive disorder cases: BMI and other confounders and overall predictive ability for current depression.? bioRxiv. Preprint posted May 21, 2018. doi:10.1101\/327239","DOI":"10.1101\/327239"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2791250\/jamapsychiatry_mousten_2022_oi_220017_1654022524.52264.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T14:26:53Z","timestamp":1675348013000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2791250"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.0645","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}